Darcy Selvidge | Gout Prevention Blog

Author "Darcy Selvidge" Page

Author Nick: DarcySelvidge
Name: Darcy Selvidge
Site:

Author Articles List:

San Antonio Chiropractor Alleviates Pain From Spinal Disc Bulges Without Surgery

Each year, many people suffer pain from bulging disc conditions and your local San Antonio chiropractor is trained to assist them with these problems. If you have a bulging disc condition you have a lot of options for therapy. Chiropractic therapy contains procedures that are non invasive in nature.

Students With Carpal Tunnel Syndrome Helped By Chiropractor In Athens GA

01.25.12 | No Comments »

Encased within the end of the palm is a tube-like narrow component known as the carpal tunnel. This is a group of blood vessels, tendons, and bone as well as a dense ligament that encircles the median nerve. Inflammation or pinching of this nerve causes a condition known as CTS which is short for Carpal Tunnel Syndrome. One chiropractor Athens GA is effectively healing CTS patients with all natural methods.

RSS

Yahoo RSS Gout Feed

Pharmos completes levotofisopam phase 2a trial on hyperuricemia, gout May 18, 2012
Pharmos Corporation today announced that it has successfully completed a proof-of-concept clinical trial using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout. […]
Regeneron: FDA panel says no to Arcalyst for gout May 8, 2012
Regeneron Pharmaceuticals Inc. said Tuesday that a Food and Drug Administration panel has recommended its drug Arcalyst not be approved as a treatment for gout.Regeneron has asked the FDA to approve the ... […]
Regeneron’s Arcalyst Fails to Win Panel Backing for Gout May 8, 2012
Regeneron Pharmaceuticals Inc. (REGN) failed to win the backing of advisers to the U.S. Food and Drug Administration to expand the use of the autoinflammatory drug Arcalyst to include patients undergoing gout treatments. […]
FDA advisers rebuff Regeneron gout drug May 8, 2012
WASHINGTON (Reuters) - U.S. drug advisers unanimously voted against Regeneron Pharmaceuticals Inc's experimental drug to prevent gout flares, based on studies that tested the drug for only 16 weeks. A panel of outside experts to the U.S. Food and Drug Administration on Tuesday voted 11-0 against approving the injectable drug, called Arcalyst, because it […]
FDA Cites Cancer Risk with Arcalyst, Regeneron’s New Gout Drug May 7, 2012
The U.S. Food & Drug Administration (FDA) has cited a cancer risk with a new gout drug by Regeneron Pharmaceuticals. Arcalyst has been approved for the treatment of rare, genetic, auto-inflammatory conditions. Arcalyst received mixed reviews in just-released FDA staff … Continue reading → […]

Google RSS Gout Feed

CURT SMITH: Alesi leaves as he governed — sadly - Victor Post May 20, 2012
CURT SMITH: Alesi leaves as he governed — sadlyVictor PostRetiring, Alesi might also have explained treating honesty like the gout. In the 2010 race, he backed traditional marriage. In spring 2011, Alesi helped the GOP-controlled Senate make ours only the sixth state to let gay and lesbian couples wed.and more » […]
Eating dry cat food may give birds gout, kidney disease - Arizona Republic May 20, 2012
Eating dry cat food may give birds gout, kidney diseaseArizona RepublicApparently, birds don't have the right kind of enzymes in their digestive tracts to process purines, so the stuff will give them gout or kidney disease. I don't believe I've ever seen a bird with gout, but I suppose these things happen.and more » […]
Gout: on the rise in Australia - Herald Sun May 19, 2012
Gout: on the rise in AustraliaHerald SunGOUT is an excruciatingly painful form of arthritis, but it can respond well to changes in lifestyle, reports Brian Johnston. Recent research suggests that the rate of gout in Australia has been steadily rising since the 1960s, and now affects 70000 ...Gout on the riseBody and Soulall 3 news articles » […]
Pharmos Corporation Announces Successful Completion Of Proof-of-concept ... - MarketWatch (press release) May 17, 2012
Pharmos Corporation Announces Successful Completion Of Proof-of-concept ...MarketWatch (press release)This phase 2a trial was conducted at the Duke Clinical Research Unit of Duke University and the principal investigator was John Sundy, MD, PhD, an expert and key opinion leader in the treatment of gout. The trial was designed to assess the safety and ...Phar […]
Regeneron's Arcalyst Fails to Win Panel Backing for Gout - BusinessWeek May 8, 2012
French TribuneRegeneron's Arcalyst Fails to Win Panel Backing for GoutBusinessWeekBy Anna Edney on May 08, 2012 Regeneron Pharmaceuticals Inc. (REGN) (REGN) failed to win the backing of advisers to the US Food and Drug Administration to expand the use of the autoinflammatory drug Arcalyst to include patients undergoing gout ...FDA advisers rebuff Regene […]

Gout Prevention BlogLearn About Gout and Gout Prevention